Zhejiang Jolly Pharmaceutical Co Ltd
300181
Company Profile
Business description
Zhejiang Jolly Pharmaceutical Co Ltd is a China-based company engaged in the production and distribution of pharmaceutical products. Its production lines include raw materials, tablets, capsules, particles and frozen dry powder injection. Its products include Wuling powder, Wuling capsule, linglianhua particle, clindamycin phosphate injection and other.
Contact
No 388 Zhiyuan North Road
Moganshan Economic
Development Zone
Deqing313200
CHNT: +86 5728281088
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
2,861
Stocks News & Analysis
stocks
Ask the analyst: How reliant are Guzman shares on international growth?
A year on from Guzman’s IPO, I catch up with Johannes Faul to explore what is baked into GYG’s valuation.
stocks
Nvidia: Back in business in China; Raising fair value estimate
Nvidia is poised to become more dominant than ever as it is allowed to sell its key H20 GPUs in China.
stocks
Our top ASX picks in every sector
These companies are our top choices for investors wanting to boost Aussie exposure.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,816.40 | 58.90 | -0.66% |
CAC 40 | 7,742.05 | 24.16 | -0.31% |
DAX 40 | 24,077.10 | 16.81 | 0.07% |
Dow JONES (US) | 43,906.96 | 116.33 | -0.26% |
FTSE 100 | 8,946.01 | 7.69 | 0.09% |
HKSE | 24,517.76 | 72.36 | -0.29% |
NASDAQ | 20,602.59 | 75.21 | -0.36% |
Nikkei 225 | 39,663.40 | 14.62 | -0.04% |
NZX 50 Index | 12,754.59 | 64.96 | 0.51% |
S&P 500 | 6,224.09 | 19.67 | -0.32% |
S&P/ASX 200 | 8,561.80 | 68.50 | -0.79% |
SSE Composite Index | 3,503.78 | 1.22 | -0.03% |